Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00777192 · ClinicalTrials.gov registry record
Longitudinal Study of Symptoms in Colorectal Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Terminated
- Registry status
- 509
- Enrollment target
NCT00777192: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT00777192 is a clinical trial that was terminated before completion, run by M.D. Anderson Cancer Center. The registered enrollment target is 509 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00777192 was terminated before completion, sponsored by M.D. Anderson Cancer Center.
- TERMINATED
- Registry status
- 509 participants
- Enrollment target
Study Summary
The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
Interventions
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 509 participants |
| Start Date | 2008-08 |
| Est. Completion | 2018-12-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00777192
The ClinicalTrials.gov registry entry for NCT00777192 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 509 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaires is the first listed.
NCT00777192 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00777192 about?
NCT00777192 is a clinical study titled "Longitudinal Study of Symptoms in Colorectal Cancer". The goal of this research study is to learn more about the pain and/or other symptoms that patients may experience within five years from CRC diagnosis. Researchers also want to learn how genetic differences may affect the symptoms patients experience from cancer and cancer therapy.
What is the current status of trial NCT00777192?
This trial is currently terminated. The enrollment target is 509 participants. The study started on 2008-08. Estimated completion is 2018-12-27.
What interventions are being tested in trial NCT00777192?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00777192?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.